Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Release of beryllium from mineral ores in artificial lung and skin surface fluids.

Duling MG, Stefaniak AB, Lawrence RB, Chipera SJ, Virji MA.

Environ Geochem Health. 2012 Jun;34(3):313-22. doi: 10.1007/s10653-011-9421-3. Epub 2011 Aug 25.

PMID:
21866318
2.

Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid.

Stefaniak AB, Virji MA, Day GA.

Chemosphere. 2011 May;83(8):1181-7. doi: 10.1016/j.chemosphere.2010.12.088. Epub 2011 Jan 19.

PMID:
21251696
3.

Release of beryllium from beryllium-containing materials in artificial skin surface film liquids.

Stefaniak AB, Virji MA, Day GA.

Ann Occup Hyg. 2011 Jan;55(1):57-69. doi: 10.1093/annhyg/meq057. Epub 2010 Aug 20.

4.

Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.

Stefaniak AB, Chipera SJ, Day GA, Sabey P, Dickerson RM, Sbarra DC, Duling MG, Lawrence RB, Stanton ML, Scripsick RC.

J Toxicol Environ Health A. 2008;71(22):1468-81. doi: 10.1080/15287390802349883.

PMID:
18836922
5.

Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.

Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E.

Appl Occup Environ Hyg. 2001 May;16(5):579-92.

PMID:
11370937
6.
7.
8.

Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: relation to risk.

Deubner DC, Sabey P, Huang W, Fernandez D, Rudd A, Johnson WP, Storrs J, Larson R.

J Occup Environ Med. 2011 Oct;53(10):1187-93. doi: 10.1097/JOM.0b013e31822cfe38.

PMID:
21926919
9.

Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution.

Stefaniak AB, Guilmette RA, Day GA, Hoover MD, Breysse PN, Scripsick RC.

Toxicol In Vitro. 2005 Feb;19(1):123-34.

PMID:
15582363
10.

Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.

Madl AK, Unice K, Brown JL, Kolanz ME, Kent MS.

J Occup Environ Hyg. 2007 Jun;4(6):448-66.

PMID:
17474035
11.

Dissolution and nanoparticle generation behavior of Be-associated materials in synthetic lung fluid using inductively coupled plasma mass spectroscopy and flow field-flow fractionation.

Huang W, Fernandez D, Rudd A, Johnson WP, Deubner D, Sabey P, Storrs J, Larsen R.

J Chromatogr A. 2011 Jul 8;1218(27):4149-59. doi: 10.1016/j.chroma.2010.11.070. Epub 2010 Dec 4.

PMID:
21167491
12.

Release of beryllium into artificial airway epithelial lining fluid.

Stefaniak AB, Virji MA, Day GA.

Arch Environ Occup Health. 2012;67(4):219-28. doi: 10.1080/19338244.2011.619218.

PMID:
23074979
13.

Comparative chronic inhalation toxicity of beryllium ores, bertrandite and beryl, with production of pulmonary tumors by beryl.

Wagner WD, Groth DH, Holtz JL, Madden GE, Stokinger HE.

Toxicol Appl Pharmacol. 1969 Jul;15:10-29. No abstract available.

PMID:
4307951
14.

Dissolution of cemented carbide powders in artificial sweat: implications for cobalt sensitization and contact dermatitis.

Stefaniak AB, Harvey CJ, Virji MA, Day GA.

J Environ Monit. 2010 Oct 6;12(10):1815-22. doi: 10.1039/c0em00269k. Epub 2010 Aug 23.

PMID:
20730217
15.

Aerosols generated during beryllium machining.

Martyny JW, Hoover MD, Mroz MM, Ellis K, Maier LA, Sheff KL, Newman LS.

J Occup Environ Med. 2000 Jan;42(1):8-18.

PMID:
10652683
16.
17.

Exposure pathway assessment at a copper-beryllium alloy facility.

Day GA, Dufresne A, Stefaniak AB, Schuler CR, Stanton ML, Miller WE, Kent MS, Deubner DC, Kreiss K, Hoover MD.

Ann Occup Hyg. 2007 Jan;51(1):67-80. Epub 2006 Jul 14.

19.

Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model.

Day GA, Hoover MD, Stefaniak AB, Dickerson RM, Peterson EJ, Esmen NA, Scripsick RC.

Exp Lung Res. 2005 Apr;31(3):341-60.

PMID:
15962713
20.

Beryllium contamination and exposure monitoring in an inhalation laboratory setting.

Muller C, Audusseau S, Salehi F, Truchon G, Chevalier G, Mazer B, Kennedy G, Zayed J.

Toxicol Ind Health. 2010 Feb;26(1):39-45. doi: 10.1177/0748233709359276. Epub 2010 Jan 7.

PMID:
20056744
Items per page

Supplemental Content

Write to the Help Desk